Innoviva Inc

INVAStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$20.23

Today

-3.5%

YTD

+5.3%

About

Innoviva Inc. (INVA) is a global holding company with a portfolio of royalties. Innoviva Inc. partners with companies that specialise in medicine development primarily for respiratory and cardiovascular diseases. Operating within the biotechnology industry, Innoviva Inc. collaborates with partners such as Glaxo Group Limited (GSK) and other healthcare investments and assets to develop areas of unmet medical need. The company’s portfolio includes respiratory assets partnered with GSK for multiple respiratory disorders. Monitor the INVA share price by adding it to your eToro watchlist.

Price chart

Closing price history for INVA (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)3.70

P/S (TTM)4.34

P/B (TTM)1.22

Market cap$1.64B

Cap tierSmall-cap

Industry avg P/E-43.29

Profitability

Gross margin71.36%

EBIT margin36.93%

Net margin183.93%

ROE50.72%

ROA32.63%

Earnings & Revenue

Revenue (TTM)$434.49M

Revenue growth (1Y)+13.3%

EPS (TTM)$6.01

Free cash flow$181.97M

Total debt$331.42M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.25

Employees159

Next earnings4 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.